Press Releases
Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively
Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million
Balance sheet strength with $86 million cash and no significant debt maturities until 2029
Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET
NEW YORK, Feb. 9, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a... (continue reading...)
HONG KONG, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Kea, the neobanking group redefining business finance through its "human-touch" model, today announced a major strategic expansion into the Asian market. Debuting at Consensus 2026, Kea aims to dismantle the barriers that have left a $2.5 trillion Trade Finance Gap in the region, leaving innovative SMEs underserved by traditional financial institutions.
As global banking becomes increasingly automated, a dangerous... (continue reading...)
NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the promotion of Kate Rochlin, Ph.D., to President and Chief Operating Officer, effective immediately.
Dr. Rochlin has served as IN8bio’s Chief Operating Officer since December 2021, following her tenure as Vice President and... (continue reading...)
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that BlackRock, Inc. has notified the company that it now holds 6,729,003 shares, corresponding to 8.51% of the total voting rights and share capital (unchanged). Additionally, BlackRock, Inc. controls voting rights attached to financial instruments amounting to 1.55% (previously 1.45%). In total, BlackRock, Inc. control 10.07% of the company’s voting rights (previously 9.97%).ABOUT... (continue reading...)
PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting researchers the right tool for the job, launched Stuntman today, a next-generation automation platform that combines native, natural-language AI with fully flexible hardware to fundamentally change how scientists interact with automation. Stuntman lets teams get answers faster and iterate with less friction, using a platform that adapts to their science... (continue reading...)
More Press Releases
View Older Stories-
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
-
Dufferin West Exploration Program Advances as Geophysical Team Mobilizes
-
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
-
The McMansion era is over: How American homes have changed in 20 years
-
As Deathcare Demographics Shift, AI Platform Aims to Support Next-Gen Funeral Directors
-
Everfi and Partners Invest More Than $1.5 Million in Student Scholarships to Expand College Access and Strengthen Financial Opportunity
-
Activation Capital Expands Frontier BioHealth and Strengthens Its Continuum of Support for Life Sciences Founders
-
Tidal Cyber Introduces Waves of Influence Thought Leadership Program
-
Leidos enhancing information sharing, decision making across U.S. security agencies
-
PackageX Scales Vision AI Execution Platform for Logistics Operations at Manifest 2026
-
D.C. Court of Appeals Leaves in Place Dismissal of OAG Claims Against EarnIn
-
XBP Global Named to Newsweek’s America’s Greatest Workplaces for Culture, Belonging & Community 2026
-
Hood College Partners with Miss Maryland's Teen, Miss America's Scholarship Foundation to Offer Scholarships to Competitors
-
Stoneway Agency Expands Partnership With Subtle Bodies to Lead Product Development and Reformulation
-
New Era Introduces Team USA Collection for Milano Cortina 2026 Winter Games
-
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
-
Universal Corporation Appoints Steven S. Diel as Chief Financial Officer
-
flyExclusive Reports Record Preliminary Unaudited Results for the Fourth Quarter and Full Year 2025, Capping a Transformational Year with Expected Positive Adjusted EBITDA in Fourth Quarter 2025
-
QAD | Redzone and TCS Announce Strategic Partnership to Accelerate AI-Driven Transformation in Manufacturing
-
Motorcar Parts of America Reports Fiscal Third Quarter Results
-
MassPay Closes Breakthrough 2025 with 286% Growth, Major Partnership Milestones
-
Ford Amphitheater Named to Billboard's 2026 Top Music Venues List
-
Churchill Capital Corp IX Reschedules Date of Extraordinary General Meeting
-
First Financial of Maryland Federal Credit Union Taps Scienaptic AI to Enhance Credit Decisioning and Improve Member Access and Lending Efficiency
-
Impactive Capital Nominates Four Candidates to WEX Board
-
INTURAI VENTURES ANNOUNCE FIRST ORDER SECURED WITH NORTH AMERICAN DEFENCE CONTRACTOR
-
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
-
DWHP Announces 2026 Staff Promotions
-
Evecxia Doses First Patient in Phase 1b Brain Target Engagement Study of Serotonin Synthesis Amplification Therapy
-
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
-
Beverly Hills Plastic Surgery® Launches the Eternal G.L.O.W. Initiative
-
Clearspeed Strengthens Leadership Team as Dual-Use Technology Gains Momentum
-
AMPLIFY Tracks Supreme Court Cruise Case With Major Implications for Cruise-Ship Injury and Maritime Liability
-
PulteGroup Announces Appointment of Kristin Gannon to its Board of Directors
-
AI Killed Big Game Ad Effectiveness: Human-Centric Stories Won the Night
-
New Yamaha Marine Systems Company, Inc. Portal Highlights Capabilities, Broadens Yamaha’s Manufacturing Scope
-
The Global Automotive Hall of Fame Unveils Its Class of 2026
-
Best Upon Request Announces Ownership Transition and New CEO
-
Billings Homebuyers Announces 3-Step Home Selling Process in Billings, MT
-
Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP
-
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
-
Flywire to Announce Fourth Quarter 2025 Results on February 24, 2026
-
Accelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call
-
GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care
-
Groups Recover Together Releases 2026 Annual Outcomes Report with Industry-Leading Results for Treatment Retention, Remission, Cost Savings, and Mortality Reduction for Addiction Care
-
JND Legal Administration Appoints Michallynn Demiter as Senior Director of Innovation and Strategy
-
Tastee Apple Inc. Expands Its Confectionery Footprint with Strategic Acquisition of Art of Sucre LLC
-
Global e∙dentity™ Announces End of Conditional Licensing Agreement with FDI Advisory Group
-
Savaria announces the acquisition of Baxter Residential Elevators
-
'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
